Loading...
Loading...
India accounts for a significant share of global Valacyclovir exports, with 113+ registered manufacturers shipping to buyers across 70+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 36.1% (export value: $33.7M). Close behind, HETERO LABS LIMITED (13.7%, $12.8M). AUROBINDO PHARMA LTD (1.7%, $1.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Valacyclovir from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Valacyclovir export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 36.1% share, shipping $33.7M worth of product across 62 shipments. The second-largest exporter, HETERO LABS LIMITED, contributes $12.8M (13.7%) to the overall market. Combined, the top two suppliers alone account for 49.9% of all Valacyclovir exports, indicating a relatively concentrated supply base.
Across all 113 tracked manufacturers, the total Valacyclovir export value stands at $93.2M from 2.5K shipments. The market average shipment value is $36.7K. The single largest buyer relationship in terms of trade value is MYLAN PHARMACEUTICALS ULC, receiving $16.2M worth of product.
The combined buyer network spans 9 named purchasing companies, including MYLAN PHARMACEUTICALS ULC, VIATRIS PHARMACEUTIC, XXMBEXXPHAXXACEXXICAXX IXX, XXNDOXXPTYXXTD, NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS and 4 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
MYLAN LABORATORIES LIMITED is the first-largest Valacyclovir exporter from India, with a market share of 36.1% and a total export value of $33.7M across 62 shipments. Their average shipment value of $543.0K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MYLAN PHARMACEUTICALS ULC — $16.2M across 30 shipments (48.2% of this supplier's total exports)
• MYLAN PHARMACEUTICALS ULC — $13.1M across 24 shipments (39.0% of this supplier's total exports)
• VIATRIS PHARMACEUTIC — $2.9M across 5 shipments (8.5% of this supplier's total exports)
• MYLAN PHARMACEUTICALS ULC — $992.8K across 2 shipments (2.9% of this supplier's total exports)
• MYLAN PHARMACEUTICALS ULC — $441.9K across 1 shipments (1.3% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $543.0K is 1378% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
HETERO LABS LIMITED is the second-largest Valacyclovir exporter from India, with a market share of and a total export value of across . Their average shipment value of is
Once Valacyclovir leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED, it travels to 5 destination markets with a combined import value of $93.2M. United States absorbs the largest share at 87.2% ($81.2M), followed by Canada (4.0%) and Taiwan (3.3%).
In United States — the top destination — named importers include MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC, XXMBEXXPHAXXACEXXICAXX IXX. In Canada, key buyers are JAMP PHARMA CORPORATION, MYLAN PHARMACEUTICALS ULC, AURO PHARMA INC.
This geographic spread reflects Valacyclovir's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Valacyclovir exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
United States ranks as the first-largest destination for Valacyclovir imports from India, with a total trade value of $81.2M across 189 shipments — representing a 87.2% share of all Valacyclovir exports. The average shipment value of $429.8K is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations. This market is served by 11 tracked buyers.
Named Valacyclovir importers in United States: MYLAN PHARMACEUTICALS INC, is the largest buyer, accounting for 25.3% ($20.5M) of this market's total imports.
• MYLAN PHARMACEUTICALS INC, — $20.5M (25.3% of United States's total)
• MYLAN PHARMACEUTICALS INC — $14.9M (18.3% of United States's total)
• XXMBEXXPHAXXACEXXICAXX IXX — $9.3M (11.4% of United States's total)
Key Insight: United States's per-shipment average of $429.8K (1070% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Valacyclovir imports from India.
Latest developments and market context
Detailed market intelligence for Valacyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
HETERO LABS LIMITED serves 5 named buyers in our database. XXMBEXXPHAXXACEXXICAXX IXX is the dominant customer, accounting for 72.4% of this supplier's tracked business. Top customers include:
• XXMBEXXPHAXXACEXXICAXX IXX — $9.3M across 182 shipments (72.4% of this supplier's total exports)
• TO THE ORDER OF — $2.8M across 55 shipments (21.7% of this supplier's total exports)
• TO — $305.4K across 6 shipments (2.4% of this supplier's total exports)
• XXNDOXXPTYXXTD — $284.5K across 6 shipments (2.2% of this supplier's total exports)
• TO THE ORDER — $155.8K across 3 shipments (1.2% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED's per-shipment value of $51.0K is 39% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
AUROBINDO PHARMA LTD is the third-largest Valacyclovir exporter from India, with a market share of 1.7% and a total export value of $1.6M across 41 shipments. Their average shipment value of $39.5K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LTD serves 3 named buyers in our database. NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS is the dominant customer, accounting for 61.0% of this supplier's tracked business. Top customers include:
• NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS — $988.0K across 25 shipments (61.0% of this supplier's total exports)
• AURO PHARMA INC — $408.6K across 10 shipments (25.2% of this supplier's total exports)
• AURO PHARMA INC — $222.3K across 6 shipments (13.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $39.5K is 8% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
V S INTERNATIONAL PRIVATE LIMITED is the fourth-largest Valacyclovir exporter from India, with a market share of 1.3% and a total export value of $1.2M across 37 shipments. Their average shipment value of $33.5K is below the market average of $36.7K, reflecting a high-volume, competitive pricing strategy.
V S INTERNATIONAL PRIVATE LIMITED serves 2 named buyers in our database. JAMP PHARMA CORPORATION is the dominant customer, accounting for 86.5% of this supplier's tracked business. Top customers include:
• JAMP PHARMA CORPORATION — $1.1M across 32 shipments (86.5% of this supplier's total exports)
• JAMP PHARMA CORPORATION — $168.0K across 5 shipments (13.5% of this supplier's total exports)
Key Insight: V S INTERNATIONAL PRIVATE LIMITED operates with high shipment frequency (37 shipments) at a per-shipment value of $33.5K, indicating a broad distribution network with many smaller, regular orders.
AUROBINDO PHARMA LIMITED is the fifth-largest Valacyclovir exporter from India, with a market share of 1.0% and a total export value of $935.5K across 4 shipments. Their average shipment value of $233.9K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LIMITED serves 2 named buyers in our database. NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS is the dominant customer, accounting for 75.3% of this supplier's tracked business. Top customers include:
• NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS — $704.8K across 3 shipments (75.3% of this supplier's total exports)
• AURO PHARMA INC — $230.7K across 1 shipments (24.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $233.9K is 537% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
CIPLA LIMITED is the fifth-largest Valacyclovir exporter from India, with a market share of 0.3% and a total export value of $325.0K across 15 shipments. Their average shipment value of $21.7K is below the market average of $36.7K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 2 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the dominant customer, accounting for 57.7% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $187.4K across 9 shipments (57.7% of this supplier's total exports)
• SUCCESS INTER LINK P — $137.5K across 6 shipments (42.3% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $21.7K, indicating a broad distribution network with many smaller, regular orders.
Canada ranks as the second-largest destination for Valacyclovir imports from India, with a total trade value of $3.7M across 44 shipments — representing a 4.0% share of all Valacyclovir exports. The average shipment value of $83.7K is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Valacyclovir importers in Canada: JAMP PHARMA CORPORATION is the largest buyer, accounting for 35.7% ($1.3M) of this market's total imports.
• JAMP PHARMA CORPORATION — $1.3M (35.7% of Canada's total)
• MYLAN PHARMACEUTICALS ULC — $992.8K (26.9% of Canada's total)
• AURO PHARMA INC — $639.3K (17.4% of Canada's total)
Key Insight: Canada's per-shipment average of $83.7K (128% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Valacyclovir imports from India.
Taiwan ranks as the third-largest destination for Valacyclovir imports from India, with a total trade value of $3.0M across 0 shipments — representing a 3.3% share of all Valacyclovir exports. The average shipment value of $3.0M is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Taiwan's per-shipment average of $3.0M (8197% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Taiwan is a key market for Valacyclovir imports from India.
Sweden ranks as the fourth-largest destination for Valacyclovir imports from India, with a total trade value of $1.9M across 0 shipments — representing a 2.0% share of all Valacyclovir exports. The average shipment value of $1.9M is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Sweden's per-shipment average of $1.9M (4967% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sweden is a key market for Valacyclovir imports from India.
Saudi Arabia ranks as the fifth-largest destination for Valacyclovir imports from India, with a total trade value of $611.4K across 7 shipments — representing a 0.7% share of all Valacyclovir exports. The average shipment value of $87.3K is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Valacyclovir importers in Saudi Arabia: SAUDI AMAROX FOR INDUSTRY COMPANY is the largest buyer, accounting for 91.0% ($556.4K) of this market's total imports.
• SAUDI AMAROX FOR INDUSTRY COMPANY — $556.4K (91.0% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $87.3K (138% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Valacyclovir imports from India.
Top supplier: 5 customers
6 suppliers → 70 countries
Network value: $93.2M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,537 Verified Shipments
113 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists